Mounjaro Price Increase UK: Impacts on Access a...

By Staff Writer

September 1, 2025

Eli Lilly is raising Mounjaro's UK price by 170% on September 1, 2025. The highest dose will jump from £122 to £330 monthly. But the company has negotiated discounts with pharmacies. This will lower the effective price to £247.50. This hike aims t...
NICE Endorses Breakthrough Bladder Cancer Treatment for Enhanced Survival
UK Pharmaceutical Pricing Analysis: Impasse in VPAG Review Undermines Patient...
TAVI Cost-Effectiveness in Brazil: Balancing Coverage Expansion and Economic ...
Evolving Strategies in Type 2 Diabetes Management: NICE Guideline Update 2025
Assessment of Glofitamab With Gemcitabine in DLBCL Reveals No Additional Benefit
Key Decisions on Health Technology Assessment at ACP124: Implications for Rar...
Eli Lilly’s Innovation Statement: Advocating Drug Pricing Reforms
Rare Medications Coverage in the Netherlands: Price Reductions Required
Strengthening the U.S. Pharmaceutical Supply Chain: Establishing a Strategic ...
Most Expensive Drugs 2025: Trends and Implications in US Pharma Pricing
Urgent Care Effectiveness: Exploring Canadian Centre Models and Health System...
France’s HAS Denies Ribociclib Breast Cancer Therapy for Early HR+/HER2...